Improving Outcomes in Patients With Cardiovascular Seasonality
RESILIENCE
Tailored, Interventional Health Care Program Designed to Address Seasonal Vulnerability in Patients With Chronic Heart Disease and Multimorbidity: the REsilience to Seasonal ILlness and Increased Emergency admissioNs CarE (RESILIENCE) Trial
1 other identifier
interventional
203
1 country
1
Brief Summary
Despite a range of evidence-based programs to identify high-risk patients and apply strategies to keep them out of hospital, a growing number of cases are "resistant" to such programs. These "seasonal frequent flyers" routinely overwhelm hospital services. The investigators have identified vulnerability to provocation of seasonal and acute weather changes ("seasonality") as a major driver of preventable/costly hospitalisations in typically older patients with heart disease and multimorbidity subject to gold-standard care. From this research the investigators developed the RESILIENCE Program which is tailored to each person and designed to assist the participants to become more "resilient" to changes in the weather. The overall aim of the RESILIENCE Trial is to demonstrate the cost-effectiveness of an individually tailored, interventional health care program designed to address the debilitating, costly and deadly phenomenon of seasonal vulnerability in a growing number of individuals admitted to hospital with chronic heart disease and multimorbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cardiovascular-diseases
Started Nov 2020
Typical duration for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2020
CompletedFirst Posted
Study publicly available on registry
November 4, 2020
CompletedStudy Start
First participant enrolled
November 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2023
CompletedMarch 27, 2024
March 1, 2024
2.7 years
October 29, 2020
March 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Days-alive-out-of-hospital (DAOH)
Defined as the proportion of maximal days follow-up where the study participant was not admitted to hospital and alive. DAOH data will be collected from hospital records. During minimum 12-month follow-up, the pre-specified threshold for a clinically significant effect in favour of the RESILIENCE Program is a 10% increase in DOAH compared to "standard care".
12-months (minimum) post randomisation to study census (July 2023)
Secondary Outcomes (3)
Overall pattern of hospitalization
12-months (minimum) post randomisation to study census
Number of community care visits
12-months (minimum) post randomisation to study census
Healthcare costs
12-months (minimum) post randomisation to study census
Study Arms (2)
Standard Care Group
NO INTERVENTIONParticipants will receive the standard care provided by their institution.
RESILIENCE Program group
ACTIVE COMPARATORParticipants will receive the RESILIENCE Program on top of the standard care provided by their institution.
Interventions
In addition to the standard care participants would normally receive (including exposure to any standard hospital avoidance programs), the 150 participants assigned to the RESILIENCE Program group will receive a combination of strategies designed to promote seasonal resilience. This includes profiling of seasonal vulnerability; a 60-80 minute home visit by the RESILIENCE Nurse to assess physiological status, behavioural adaptations, environment, and modulating factors; a dedicated RESILIENCE Clinic with a dedicated RESILIENCE physician to develop a long-term plan to help promote/maintain seasonal resilience and; a structured follow-up over the next 12 months to monitor and adjust the participant's status and management from a seasonal perspective.
Eligibility Criteria
You may qualify if:
- Individual aged 18 years and over.
- Admitted to hospital due to a medical emergency for any reason but with a chronic form of heart disease (i.e. including. coronary artery disease, atrial fibrillation and/or heart failure) requiring treatment
- Multimorbidity (defined as two or more chronic conditions requiring active treatment/management).
- A planned discharge to home within a 10km radius of the hospital.
You may not qualify if:
- Living in residential aged care
- Terminal illness and/or unable to give informed consent
- Died during index admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sheila Patellead
- University of Melbournecollaborator
Study Sites (1)
Austin Health
Heidelberg, Victoria, 3084, Australia
Related Publications (2)
Stewart S, Patel SK, Lancefield TF, Sampaio Rodrigues T, Doumtsis N, Moini N, Harley A, Vaughan-Fowler ER, Chan YK, Chen A, Chye D, Liew DF, McMaster C, Ramchand J, Yates PA, Kwong JC, McDonald CF, Burrell LM. Promoting resilience to weather-related and seasonal provocations to health in people with multimorbid heart disease: a prospective pragmatic, randomised trial. Med J Aust. 2025 Jul 21;223(2):77-84. doi: 10.5694/mja2.52699. Epub 2025 Jun 24.
PMID: 40556316DERIVEDStewart S, Patel SK, Lancefield TF, Rodrigues TS, Doumtsis N, Jess A, Vaughan-Fowler ER, Chan YK, Ramchand J, Yates PA, Kwong JC, McDonald CF, Burrell LM. Vulnerability to environmental and climatic health provocations among women and men hospitalized with chronic heart disease: insights from the RESILIENCE TRIAL cohort. Eur J Cardiovasc Nurs. 2024 Apr 12;23(3):278-286. doi: 10.1093/eurjcn/zvad076.
PMID: 37625011DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Louise M Burrell, MD
University of Melbourne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The people assessing the outcomes will be masked
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Research Fellow
Study Record Dates
First Submitted
October 29, 2020
First Posted
November 4, 2020
Study Start
November 25, 2020
Primary Completion
July 28, 2023
Study Completion
July 28, 2023
Last Updated
March 27, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning following main results publication; no end date determined
- Access Criteria
- Case-by-case basis at the discretion of the Primary Sponsor and RESILIENCE TRIAL Investigators and provide a methodologically sound proposal.
Trial data will be disseminated in the form of a publication to a relevant clinical journal and presentation at appropriate scientific conferences. Individual participant data that underlie the published results, may be shared on request by the RESILIENCE TRIAL Investigators at the completion of the trial and reporting of the endpoints.